Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunologic Deficiency Syndrome, Acquired”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06971367
What this trial is testing

IBIS Megastudy of Interventions to Encourage HIV Retesting

Who this might be right for
HIV
University of California, San Francisco 40,000
Not applicableEnrolling By InvitationNCT07541131
What this trial is testing

Lower Intersecting HIV-related Stigmas to Facilitate Treatment as Prevention (LIFT)

Who this might be right for
Stigma, SocialDrug Abuse IllicitHIV (Human Immunodeficiency Virus)
University of California, San Diego 80
Large-scale testing (Phase 3)Study completedNCT00002339
What this trial is testing

Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems

Who this might be right for
Candidiasis, EsophagealHIV Infections
Pfizer 100
Not applicableStudy completedNCT01580657
What this trial is testing

Experimental Analysis of HIV Risk Assessment Reactivity in South African Clinics

Who this might be right for
HIV Prevention and Assessment Reactivity
Medical College of Wisconsin 1,728
Not applicableStudy completedNCT00002113
What this trial is testing

A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer 64
Testing effectiveness (Phase 2)Study completedNCT03435146
What this trial is testing

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

Who this might be right for
Respiratory Tract InfectionsHIV Infections
The Aurum Institute NPC 135
Not applicableNot Yet RecruitingNCT06926569
What this trial is testing

Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis

Who this might be right for
HIV/AIDS-associated Talaromycosis
Shanghai Public Health Clinical Center 116
Early research (Phase 1)WithdrawnNCT00385554
What this trial is testing

Botswana Study of UC-781 Vaginal Microbicide

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention
Not applicableLooking for participantsNCT06904820
What this trial is testing

Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®

Who this might be right for
Viral Hepatitis
University Hospital, Limoges 2,300
Not applicableStudy completedNCT00000759
What this trial is testing

Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 675
Not applicableStudy completedNCT05335096
What this trial is testing

An AI-based mHealth Intervention to Improve HIV Testing

Who this might be right for
HIV Infections
Yale University 307
Not applicableStudy completedNCT04320186
What this trial is testing

Community Influences Transitions in Youth Health (CITY) Health II - Center for the Study of Community Health

Who this might be right for
Sexually Transmitted DiseasesHIV Infections
University of Alabama at Birmingham 334
Testing effectiveness (Phase 2)Study completedNCT00201123
What this trial is testing

Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs

Who this might be right for
TuberculosisAIDS-related Complex
NYU Langone Health 89
Large-scale testing (Phase 3)Study completedNCT00164580
What this trial is testing

Community Intervention Trial for Youth (CITY) Study

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 12,000
Not applicableLooking for participantsNCT06046079
What this trial is testing

Predictors of Health Service Utilizations Among Key Population in Washington DC

Who this might be right for
Pre-exposure ProphylaxisHIVHealth Behavior
Us Helping Us, People Into Living, Inc. 100
Early research (Phase 1)Study completedNCT00000761
What this trial is testing

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT01784783
What this trial is testing

Home-based Partner Education and Testing (HOPE) Study

Who this might be right for
HIV
University of Washington 601
Testing effectiveness (Phase 2)UnknownNCT02441231
What this trial is testing

Probiotic Visbiome for Inflammation and Translocation in HIV II

Who this might be right for
HIV-1 Infection
University Health Network, Toronto 36
Not applicableStudy completedNCT02191202
What this trial is testing

Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression

Who this might be right for
HIV Infections
Boehringer Ingelheim 283
Not applicableStudy completedNCT00002172
What this trial is testing

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

Who this might be right for
HIV Infections
The Immune Response Corporation
Next Page